Article Versions Notes

Yang C-Y, Liu C-R, Chang IY-F, OuYang C-N, Hsieh C-H, Huang Y-L, Wang C-I, Jan F-W, Wang W-L, Tsai T-L, et al. Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts. Cancers. 2020; 12(7):1726. https://doi.org/10.3390/cancers12071726

Yang, Chia-Yu, Chiao-Rou Liu, Ian Yi-Feng Chang, Chun-Nan OuYang, Chia-Hsun Hsieh, Yen-Lin Huang, Chun-I Wang, Fei-Wen Jan, Wan-Ling Wang, Ting-Lin Tsai, and et al. 2020. "Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts" Cancers 12, no. 7: 1726. https://doi.org/10.3390/cancers12071726

Yang, C.-Y., Liu, C.-R., Chang, I. Y.-F., OuYang, C.-N., Hsieh, C.-H., Huang, Y.-L., Wang, C.-I., Jan, F.-W., Wang, W.-L., Tsai, T.-L., Liu, H., Tseng, C.-P., Chang, Y.-S., Wu, C.-C., & Chang, K.-P. (2020). Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts. Cancers, 12(7), 1726. https://doi.org/10.3390/cancers12071726